Complete report 8,500. nbsp;DataPack (test volumes, sales forecasts, supplier shares) 5,500.
This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
Competing in the Global Therapeutic Drug Monitoring (TDM) Market is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five- and ten-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.nbsp
Contains 313 pages and 83 tables
SIMILAR MARKET STUDIES
This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Roche and its main competitors, as well as a profile of the company’s diagnostics business. List of Tables Clinical Chemistry and Immunodiagnostics ...
September 2015 | $5000 | View Details >>
This new report from VPGMarketResearch.com provides analysis of Glycosylated Hemoglobin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Cancer ...
July 2016 | $0 | View Details >>
Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300. VPGMarketResearch .com presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews current and emerging assays; analyzes potential applications of ...
July 2016 | $0 | View Details >>
The report presents a detailed analysis of the Pseudomonas diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pseudomonas definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market ...
February 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research